CA2058398A1 - Derives d'acide 1,4-benzothiazine-2-acetique; methode de preparation - Google Patents

Derives d'acide 1,4-benzothiazine-2-acetique; methode de preparation

Info

Publication number
CA2058398A1
CA2058398A1 CA2058398A CA2058398A CA2058398A1 CA 2058398 A1 CA2058398 A1 CA 2058398A1 CA 2058398 A CA2058398 A CA 2058398A CA 2058398 A CA2058398 A CA 2058398A CA 2058398 A1 CA2058398 A1 CA 2058398A1
Authority
CA
Canada
Prior art keywords
same
group
benzothiazine
processes
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2058398A
Other languages
English (en)
Other versions
CA2058398C (fr
Inventor
Tomoji Aotsuka
Hiroshi Hosono
Toshio Kurihara
Yoshiyuki Nakamura
Tetsuo Matsui
Fujio Kobayashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Senju Pharmaceutical Co Ltd
Welfide Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2058398A1 publication Critical patent/CA2058398A1/fr
Application granted granted Critical
Publication of CA2058398C publication Critical patent/CA2058398C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/16—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
CA002058398A 1990-12-27 1991-12-23 Derives d'acide 1,4-benzothiazine-2-acetique; methode de preparation Expired - Fee Related CA2058398C (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP415316/1990 1990-12-27
JP41531690 1990-12-27
JP21934691 1991-08-06
JP219346/1991 1991-08-06

Publications (2)

Publication Number Publication Date
CA2058398A1 true CA2058398A1 (fr) 1992-06-28
CA2058398C CA2058398C (fr) 2000-02-15

Family

ID=26523070

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002058398A Expired - Fee Related CA2058398C (fr) 1990-12-27 1991-12-23 Derives d'acide 1,4-benzothiazine-2-acetique; methode de preparation

Country Status (10)

Country Link
US (1) US5252571A (fr)
EP (1) EP0492667B1 (fr)
JP (1) JP2729430B2 (fr)
KR (1) KR0156581B1 (fr)
AU (1) AU634109B2 (fr)
CA (1) CA2058398C (fr)
DE (1) DE69118850T2 (fr)
DK (1) DK0492667T3 (fr)
ES (1) ES2085950T3 (fr)
IE (1) IE914455A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2122370A1 (fr) * 1992-08-31 1994-03-17 Yoichi Kawashima Derives 3-oxo-1,4-benzothiazine
JPH06279453A (ja) * 1993-03-29 1994-10-04 Green Cross Corp:The ピリドチアジン酢酸誘導体，その製法及びその用途
US5556841A (en) * 1994-02-04 1996-09-17 Santen Pharmaceutical Co., Ltd. Thiazine or thiomorpholine derivatives
US5700819A (en) * 1994-11-29 1997-12-23 Grelan Pharmaceutical Co., Ltd. 2-substituted benzothiazole derivatives and prophylactic and therapeutic agents for the treatment of diabetic complications
JP2003119142A (ja) * 1997-03-31 2003-04-23 Mitsubishi Pharma Corp 糖化蛋白変性物質生成阻害剤
AU5246400A (en) * 1999-06-14 2001-01-02 Mitsubishi Pharma Corporation Process for the preparation of (-)-1,4-benzothiazine-2-acetic acid derivatives
US8158667B2 (en) 2006-08-21 2012-04-17 Kador Peter F Topical treatment of cataracts in dogs
KR20140026532A (ko) * 2011-04-29 2014-03-05 이칸 스쿨 오브 메디슨 엣 마운트 시나이 키나제 억제제

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1453465A (fr) * 1965-08-11 1966-06-03 Kuhlmann Ets Nouveaux antiozones
US3503965A (en) * 1967-12-01 1970-03-31 American Home Prod Derivatives of 1,4-benzothiazine
US3910904A (en) * 1974-08-12 1975-10-07 Monsanto Co 2-Substituted methylene-3,4-dihydro-3-oxo-2H-1,4-benzothiazine-4-acetic acid and esters thereof
IE58312B1 (en) * 1984-05-18 1993-09-08 Union Pharma Scient Appl Heterocyclic derivatives, processes for their preparation and drugs in which they are present, which are useful especially as aldose reductase inhibitors
AU602641B2 (en) * 1986-04-17 1990-10-18 Senju Pharmaceutical Co., Ltd. Thiolactam-N-acetic acid derivatives, their production and use

Also Published As

Publication number Publication date
AU9004591A (en) 1992-07-09
EP0492667A1 (fr) 1992-07-01
CA2058398C (fr) 2000-02-15
DK0492667T3 (da) 1996-07-08
JP2729430B2 (ja) 1998-03-18
DE69118850D1 (de) 1996-05-23
US5252571A (en) 1993-10-12
JPH0592961A (ja) 1993-04-16
AU634109B2 (en) 1993-02-11
IE914455A1 (en) 1992-07-01
KR0156581B1 (en) 1998-11-16
KR920012056A (ko) 1992-07-25
DE69118850T2 (de) 1997-01-09
EP0492667B1 (fr) 1996-04-17
ES2085950T3 (es) 1996-06-16

Similar Documents

Publication Publication Date Title
CA2384283A1 (fr) Procede de preparation d'un derive 4-trifluoromethylsulfinylpyrazole
AU1282495A (en) Anthranilic acid derivative
MY104627A (en) A 1-pyridylimidazole derivative and its production and use.
AU5228190A (en) Novel quinolone derivatives, preparation processes thereof, and antibacterial agents containing the same
CA2166203A1 (fr) Methodes et intermediaires pour la preparation de 5-[2-(4-(benzo-isothiazol-3-yl)piperazin-1-yl)ethyl]-6-chloro-1,3-dihydro-indol-2-one
DK0567271T3 (da) Steroidderivater til behandling af prostatahypertrofi, fremgangsmåde til fremstilling heraf og anvendelser heraf
AU2722095A (en) Novel pyrrolocarbazoles
CA2058398A1 (fr) Derives d'acide 1,4-benzothiazine-2-acetique; methode de preparation
GR3033350T3 (en) Use of Beta-aminopropionic acid derivatives as fungicides
EP0503453A3 (en) New process for the production of cephalosporines and novel intermediates in this process
EP0760362A4 (fr) Nouveau derive de diaminomethylidene
GB8906822D0 (en) Heterocyclic compounds
EP0987255A3 (fr) Dérivés d' aminoquinazolinone (thione) substitués
CA2088702A1 (fr) Derives de l'acide aminobenzoique
EP1227081A4 (fr) Procede de preparation de derives d'acide oxyminoalcanoique
AU9462298A (en) Process for producing 3-cephem compounds
AU4355696A (en) Substituted amidinonaphthyl ester derivatives
AU622590B2 (en) Lowering of blood uric acid levels
ATE67194T1 (de) Thiadiazolylacetamid-derivate, verfahren zu ihrer herstellung und ihre verwendung.
PL313162A1 (en) Derivatives of 4-alkyl thiopyrimidin-5-nyloacetic acud, method of obtaining them, method of fighting against fitopathogenic fungi and fungicidal composition
EP0882713A4 (fr) Procede pour la preparation de derives d'halogenopyridine
IE892884L (en) Microbicides
ZA965092B (en) Process for the preparation of alpha-methyl-thiopheneacetic acid derivatives
WO2001012597A3 (fr) Procede de preparation de quinoleine-5,8-diones
ATE104975T1 (de) Verfahren zur herstellung von imidazol-derivaten.

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed